ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,547Medicare Part D Prescriptions Filled, Including Refills

Rank: 221 out of 2343

$789K Total Retail Price of All Prescriptions

Rank: 248 out of 2343

453 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 453 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

15% of this provider’s 453 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 13,404 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
LEVOTHYROXINE SODIUM 698 661 1 2
FUROSEMIDE 647 599 2 6
JANTOVEN 500 499 3 81
WARFARIN SODIUM 483 417 4 8
SIMVASTATIN 477 428 5 1
OMEPRAZOLE 421 385 6 4
HYDROCODONE-ACETAMINOPHEN 421 395 S3 6 13
METOPROLOL TARTRATE 362 361 8 7
LISINOPRIL 296 283 9 3
AMLODIPINE BESYLATE 287 269 10 5
DONEPEZIL HCL 274 257 11 21
MIRTAZAPINE 263 252 12 41
CITALOPRAM HBR 249 236 13 17
SERTRALINE HCL 217 208 14 20
GABAPENTIN 217 207 14 16
KLOR-CON M20 212 199 16 44
DIOVAN 177 159 17 23
NAMENDA 172 172 18 36
QUETIAPINE FUMARATE 170 170 19 77
JANUVIA 166 147 20 50
DIGOXIN 158 152 21 35
ATORVASTATIN CALCIUM 155 151 22 10
METFORMIN HCL 153 152 23 9
POLYETHYLENE GLYCOL 3350 148 145 24 54
SYNTHROID 145 138 25 40
BUMETANIDE 128 111 26 91
POTASSIUM CHLORIDE 127 127 27 18
ATENOLOL 125 114 28 12
IPRATROPIUM-ALBUTEROL 108 106 29 99
OXYCODONE-ACETAMINOPHEN 107 94 S2 30 49
TRAZODONE HCL 99 71 31 53
CARVEDILOL 97 90 32 27
LANTUS 95 87 33 51
ZOLPIDEM TARTRATE 93 73 34 24
CLOTRIMAZOLE-BETAMETHASONE 91 86 35 127
GLIPIZIDE 90 80 36 56
SEROQUEL 89 89 37 171
ISOSORBIDE MONONITRATE ER 80 70 38 32
RISPERIDONE 77 77 39 61
AMLODIPINE BESYLATE-BENAZEPRIL 76 76 40 59
QUINAPRIL HCL 76 76 40 73
ALLOPURINOL 76 68 40 31
SULFAMETHOXAZOLE-TRIMETHOPRIM 76 63 40 120
TOPIRAMATE 75 52 44 220
DIVALPROEX SODIUM 72 72 45 105
CLOPIDOGREL 72 64 45 26
PREDNISONE 71 71 47 37
FENTANYL 70 68 S2 48 69
PANTOPRAZOLE SODIUM 70 70 48 22
TAMSULOSIN HCL 66 66 50 29
ESCITALOPRAM OXALATE 66 52 50 55
TRAMADOL HCL 62 62 52 25
PLAVIX 60 52 53 38
LANTUS SOLOSTAR 60 56 53 101
ENALAPRIL MALEATE 58 46 55 58
CIPROFLOXACIN HCL 57 54 56 72
ARANESP 56 56 57 553
GLIMEPIRIDE 56 56 57 45
NOVOLOG 55 43 59 110
DILTIAZEM 24HR CD 55 55 59 83
FINASTERIDE 54 54 61 80
METOPROLOL SUCCINATE 52 39 62 14
LOSARTAN POTASSIUM 52 48 62 19
RANITIDINE HCL 50 40 64 43
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 24, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.